Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators.

N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.

PMID:
25399658
[PubMed - indexed for MEDLINE]
2.

Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.

Sarafoff N, Martischnig A, Wealer J, Mayer K, Mehilli J, Sibbing D, Kastrati A.

J Am Coll Cardiol. 2013 May 21;61(20):2060-6. doi: 10.1016/j.jacc.2013.02.036. Epub 2013 Mar 21.

PMID:
23524219
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis.

Chatterjee S, Ghose A, Sharma A, Guha G, Mukherjee D, Frankel R.

J Thromb Thrombolysis. 2013 Oct;36(3):223-32. doi: 10.1007/s11239-012-0838-z. Review.

PMID:
23212803
[PubMed - indexed for MEDLINE]
4.

A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations: the CLO-CLO trial.

Oberhänsli M, Lehner C, Puricel S, Lehmann S, Togni M, Stauffer JC, Baeriswyl G, Goy JJ, Cook S.

Arch Cardiovasc Dis. 2012 Nov;105(11):587-92. doi: 10.1016/j.acvd.2012.06.001. Epub 2012 Oct 4.

PMID:
23177487
[PubMed - indexed for MEDLINE]
Free Article
5.

Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, Akl EA, Lansberg MG, Guyatt GH, Spencer FA; American College of Chest Physicians.

Chest. 2012 Feb;141(2 Suppl):e637S-68S. doi: 10.1378/chest.11-2306. Erratum in: Chest. 2012 Apr;141(4):1129. Dosage error in article text.

PMID:
22315274
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].

Silber S.

Herz. 2010 Dec;35(8):558-64. doi: 10.1007/s00059-010-3401-8. German.

PMID:
21107514
[PubMed - indexed for MEDLINE]
7.

Progress in platelet medicine: focus on stent thrombosis and drug resistance.

Patel PA, Augoustides JG.

J Cardiothorac Vasc Anesth. 2010 Aug;24(4):722-7. doi: 10.1053/j.jvca.2010.04.017. Epub 2010 Jun 18. Review.

PMID:
20561798
[PubMed - indexed for MEDLINE]
8.

Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.

Campo G, Valgimigli M, Carrescia C, Carletti R, Ferrari R.

Clin Appl Thromb Hemost. 2010 Oct;16(5):591-3. doi: 10.1177/1076029609337312. Epub 2009 Jun 10.

PMID:
19520678
[PubMed - indexed for MEDLINE]
9.

Recent advances in the management of coronary artery disease: highlights from the literature.

Augoustides JG, Ramakrishna H.

J Cardiothorac Vasc Anesth. 2009 Apr;23(2):259-65. doi: 10.1053/j.jvca.2008.12.022. Review.

PMID:
19324285
[PubMed - indexed for MEDLINE]
10.

Antiplatelet drugs in cardiological practice: established strategies and new developments.

Krötz F, Sohn HY, Klauss V.

Vasc Health Risk Manag. 2008;4(3):637-45. Review.

PMID:
18827913
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.

Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E.

J Am Coll Cardiol. 2008 May 27;51(21):2028-33. doi: 10.1016/j.jacc.2008.04.002.

PMID:
18498956
[PubMed - indexed for MEDLINE]
Free Article
12.

Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.

Serebruany VL, Midei MG, Meilman H, Malinin AI, Lowry DR.

Int J Clin Pract. 2006 Jul;60(7):863-6.

PMID:
16846403
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk